TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$349.2K
Year ended 2024-12-31
2021-12-31: $100.0K2022-12-31: $4752023-12-31: $319.5K2024-12-31: $349.2K$349.2K
2021-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$349.2K+9.3%2026-05-15, From 2024-01-01
2023-12-31$319.5Kn/m2026-05-15, From 2023-01-01
2022-12-31$475n/c2023-05-15, From 2022-01-01
2021-12-31$100.0Kn/a2025-09-23, From 2021-01-01